Fangda Partners

Shanghai Office

Current View:

This content is provided by Fangda Partners.

Managing Partner: Yang Gao
Number of partners: 162
Number of other lawyers: 548
Languages:Chinese (Mandarin, Cantonese), English, French, German, Japanese

Firm Overview:
Founded in 1993, Fangda Partners is a premier law firm in the PRC. It has over 710 lawyers serving international and domestic clients on most challenging matters with seamless cooperation among its teams in Beijing, Hong Kong, Guangzhou, Shanghai and Shenzhen. The firm is highly sought after in mergers and acquisitions, private equity, TMT, capital markets, intellectual property, financial institution, anti-trust, compliance and government enforcement, and dispute resolution, especially the most challenging cross-border matters.

Main Areas of Practice:
Asset-Backed Securities
Banking & Finance
Capital Markets
Compliance & Government Enforcement
Dispute Resolution
Energy & Infrastructure
Finance Institutions
General Industries
Insolvency & Restructuring
Intellectual Property
Investment Funds
Investment Management
Labour & Employment
Life Sciences & Healthcare
Private Equity
Real Estate & Construction
Technology, Media & Telecommunications

Recent Work includes:
■ Acting for Canada Pension Plan Investment Board (CPPIB), Warburg Pincus, Discovery Capital Management LLC and Boyu Capital in its subscription of the shares issued by Ant International Co., Limited (an offshore affiliate of Ant Small and Micro Financial Services Group Co., Ltd.). The total transaction price of this round of financing, to which CPPIB, Warburg Pincus, Discovery Capital Management LLC and Boyu Capital are among the investors, is around US$ 14 billion
■ Acted for the buyer consortium led by Envision Group on its leveraged acquisition of the electric battery operations and production facilities from Nissan Motor Company and NEC and the resulting joint venture between the buyer and Nissan. The transaction was valued at more than US$1 billion
■ Acted for Eddingpharm Group (Cayman) Holdings Limited on its acquisition from Eli Lilly of the rights to two legacy antibiotic medicines in China, Ceclor and Vancocin, as well as a manufacturing facility in Suzhou that produces Ceclor, involving a total transaction price of US$375 million
■ Acted for WuXi AppTec on its placement of 68.2 million H-shares at a price of HK$108 each. The placement, which concluded on July 29, 2020, raised HK$7.4 billion. The agents included Morgan Stanley, Huatai Securities, Goldman Sachs, and J.P. Morgan
■ Acted for China Huaneng Group Co., Ltd. on its acquisition of all the equity interests in six solar power plant project companies held by GCL New Energy Holdings Limited. The purchase was made through two equity investment funds established by China Huaneng Group and others, involving an aggregate share purchase price of RMB850 million
■ Acting for EF Education First (“EF”) in connection with a major investment by the global investment firm Permira in the EF Kids & Teens Business. Permira will acquire a majority stake in the EF Kids & Teens business, with EF retaining significant ownership in the business. The completion of Permira’s investment remains subject to customary conditions
■ Acted for represented KKR in its acquisition from NVC Lighting Holding Limited (Stock Code: 02222.HK) (“NVC Lighting”) of majority interest in NVC Lighting’s China Lighting Business (“NVC China”). Following the completion of this deal, KKR owns 70% of NVC China and NVC Lighting owns the remaining 30% and receive a cash consideration. The deal amount is approximately USD 794 million
■ Acted for Alibaba Group Holding Limited in connection with its global offering and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited. The base offering size was HK$88 billion (approximately US$11.28 billion) before exercise of the underwriters’ overallotment option. The global offering is the largest ever cross-border secondary offering and is also the biggest equity offering on the SEHK since 2010
■ Acted for China International Capital Corporation (CICC) as sole sponsor and lead underwriter in the IPO and listing of China Resources Microelectronics (CRM) on the Shanghai Stock Exchange Science and Technology Innovation Board, raising approximately RMB3.8 billion (RMB 4.3 billion from the Full Exercise of the Over-Allotman Option)
■ Acted for iRay Technology Company Limited in its initial public offering and listing on the Shanghai Stock Exchange Science and Technology Innovation Board. The IPO raised a total of RMB2.2 billion from the issue of 18.2 million shares. This is the largest IPO project in the special equipment manufacturing industry on the SSE STAR Market to date
■ Acted for China International Capital Corporation Limited as joint sponsor and lead underwriter in Semiconductor Manufacturing International Corporation (SMIC)’s initial public offering and listing on the Shanghai Stock Exchange Science and Technology Innovation Board. The IPO raised over RMB46 billion (over RMB53 billion after the exercise of the over-allotment option). SMIC’s IPO is the largest on the STAR Market to date
■ Acted for Asian Infrastructure Investment Bank (AIIB) on its RMB3 billion panda bond offering on China’s interbank bond market. This is the first panda bond offering by an issuer rated AAA by international credit rating agencies after the promulgation of the current panda bond rules
■ Acted for Beijing Chengfang Huida Management Company in its subscription of 5.27 million shares Jinzhou Bank, which is listed on the Hong Kong Stock Exchange, with a total amount of RMB 10.3 billion. The subscription gave Beijing Chengfang Huida Company, a wholly-owned subsidiary of Huida approximately 37% of the enlarged total number of issued shares immediately following Completion
■ Represented Apple in disputes against Qualcomm arising from a SEP licensing scheme. There are many causes of civil action, and more than 30 patent infringement cases. The damages claimed by the parties exceeded RMB1.6 billion
■ Acted for the basketball legend Mr Michael Jordan in a series of litigation against Qiaodan Sports Company for its registration of Mr Jordan’s name as company name and trademarks before the China Supreme Court
■ Represented Conocophillips in a public interest environment litigation which is the first time that a multinational was sued in a public interest environment litigation in China. The firm has obtained favourable outcome for the client and the plaintiffs’ claims were not supported by the court
■ Advised Giorgio Armani on a complex cross-border (i.e. PRC, Hong Kong and Italy) and high-stake litigation case